b3c newswire Press Releases

• Published on November 5, 2018 - 12:45 GMT

  Orchard Therapeutics Announces Closing of $225 Million Initial Public Offering, Including the Partial Exercise of Underwriters' ...

  Boston, Mass., USA and London, UK, November 05, 2018 / B3C newswire / -- Orchard Therapeutics plc (Nasdaq: ORTX), a biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases through autologous …

  Distribution channels: Technology
• Published on October 31, 2018 - 07:48 GMT

  Orchard Therapeutics Announces Pricing of Initial Public Offering

  Boston, Mass., USA and London, UK, October 31, 2018 / B3C newswire / -- Orchard Therapeutics plc (Nasdaq: ORTX), a biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases through autologous …

  Distribution channels: Technology
• Published on October 25, 2018 - 14:11 GMT

  Elpis Biomed Human Cell Models Could Potentially Replace Animal Experiments in Drug Discovery

  Technology supported by Dr Jonathan Milner in his ELRIG Plenary Address Cambridge, UK, October 25, 2018 / B3C newswire / -- Elpis Biomed Ltd. (Elpis), a University of Cambridge spin-out developing high quality human cells via its proprietary OPTi-OX …

  Distribution channels: Technology
• Published on October 25, 2018 - 07:37 GMT

  Cristal Therapeutics Initiates Phase 2 Clinical Trial of Innovative CriPec® Nanomedicine Drug Candidate in Ovarian Cancer

  Maastricht, The Netherlands, October 25, 2018 / B3C newswire / -- Cristal Therapeutics, a clinical stage pharmaceutical company developing unique nanomedicines for the treatment of cancer and other diseases, announced today the first patient has been dosed …

  Distribution channels: Technology
• Published on October 22, 2018 - 07:32 GMT

  Polyganics Initiates First-in-Human Trial of LIQOSEAL®, its Innovative Approach for Dural Closure

  Groningen, The Netherlands, October 22, 2018 / B3C newswire / -- Polyganics, a medical technology company developing, manufacturing and commercializing bioresorbable medical devices, today announced that it has initiated enrollment of patients into a first …

  Distribution channels: Technology
• Published on October 11, 2018 - 07:55 GMT

  Not Just for Pharma Anymore: rfxcel Extends Track & Trace Solutions to Food & Beverage

  San Ramon, CA, USA, October 11, 2018 / B3C newswire / -- rfxcel, the Leader in Track and Trace Solutions for the pharmaceutical market, announced today that it is extending its leading-edge track and trace solutions to the Food and Beverage industry. Like …

  Distribution channels: Technology
• Published on October 11, 2018 - 07:55 GMT

  IME Medical Electrospinning Enters into Development Cooperation with Leading Chinese Medical Devices Company Amor Medical

  Joint optimization of groundbreaking resorbable medical device for treatment of full thickness wounds in oral cavities Waalre, The Netherlands, and Jiangsu, P.R. of China, October 11, 2018 / B3C newswire / -- Medical Technology company IME Medical …

  Distribution channels: Technology
• Published on October 5, 2018 - 10:47 GMT

  apceth to Manufacture First Potential One-Time Gene Therapy for Transfusion-Dependent Beta-Thalassemia

  Munich, Germany,  October 05, 2018 / B3C newswire / -- apceth Biopharma GmbH, a leading company for the development and manufacturing of cell and gene therapeutics, congratulates its partner bluebird bio on the acceptance and validation of its market …

  Distribution channels: Technology
• Published on October 4, 2018 - 12:09 GMT

  Orchard Therapeutics Receives EMA PRIME Designation for OTL-300, an Investigational Lentiviral Gene Therapy for the Treatment of ...

  Boston, USA and London, UK, October 04, 2018 / B3C newswire / -- Orchard Therapeutics, a leading commercial-stage biotech company dedicated to transforming the lives of patients with rare diseases through innovative gene therapies, today announced that the …

  Distribution channels: Technology
• Published on October 4, 2018 - 07:33 GMT

  MetP® Pharma Introduces Nascum®-Plus Against the Onset of Air Pollution-induced Inflammation

    Nascum®-Plus works as a protective shield on the nasal mucosa where air pollutants trigger an allergic reaction The barrier effect of Nascum®-Plus mediates anti-inflammatory and IgE-suppressive effects following the nasal exposure to allergens such as …

  Distribution channels: Technology
• Published on September 27, 2018 - 05:00 GMT

  Vetter Grants Award for Novel Idea at the Open Innovation Challenge – Injection 2.0

  Contract Development and Manufacturing Organization successfully realizes a new creative format 18 participants worked over a three month period on the ‘injection of the future’ Multidisciplinary teams developed new ideas for the use of digital trends The …

  Distribution channels: Technology
• Published on September 20, 2018 - 06:13 GMT

  Medtech Company IME Medical Electrospinning Establishes New High-Tech Production Facility to Set The World Wide Standard for ...

  Two new cleanrooms and a high-end laboratory enable the development and large scale production of electrospun scaffolds that meet the stringent requirements of the Medtech Regenerative Medicine Industry Waalre, The Netherlands, September 20, 2018 / B3C …

  Distribution channels: Technology
• Published on September 18, 2018 - 12:31 GMT

  Dominick Arena Joins Implandata Ophthalmic Products GmbH Board of Directors as Chairman

  Hannover, Germany, September 18, 2018 / B3C newswire / -- Implandata Ophthalmic Products GmbH is pleased to announce that Dominick Arena is appointed as its Chairman of the Board effective immediately. Dominick is currently an Executive Advisor for Water …

  Distribution channels: Technology
• Published on September 18, 2018 - 06:01 GMT

  Neurimmune Achieves Milestone in Collaboration with Ono Pharmaceutical

  Schlieren / Zurich, Switzerland, September 18, 2018 / B3C newswire / -- Neurimmune today announced the achievement of a key preclinical milestone in the ongoing collaboration with Ono Pharmaceutical Co., Ltd. In November 2017, the parties entered into a …

  Distribution channels: Technology
• Published on September 10, 2018 - 10:11 GMT

  Menarini Will Bring Lunaphore’s Ultra-Rapid Tissue Staining Solution LabSat™ Frozen to Market

  Lausanne, Switzerland and Florence, Italy, September 09, 2018 / B3C newswire / -- Lunaphore Technologies SA, a Swiss Company developing innovative next-generation devices for cancer tissue diagnostics, and A. Menarini Diagnostics S.r.l., one of Europe’s …

  Distribution channels: Technology
• Published on September 10, 2018 - 10:11 GMT

  RSP Systems Adds EUR 3,85 Million in a Second Closing of its Series B Funding Round, Increasing the Round Total to EUR 10,35 ...

    Odense, Denmark, September 10, 2018 / B3C newswire / -- RSP Systems A/S, the non-invasive diagnostics company, announces that it has completed second closing of its Series B round. This closing brings in an additional EUR 3,85 million making the round …

  Distribution channels: Technology
• Published on September 5, 2018 - 11:55 GMT

  Thrombolytic Science Initiates Phase 2 Clinical Trial of its Novel Treatment Regimen for Ischemic Stroke

  Study Seeks to Confirm Efficacy and Safety of Next-generation Clot-dissolving Therapy Consisting of Low-dose tPA and HisproUK Cambridge, Mass., USA, September 05, 2018 / B3C newswire / -- Thrombolytic Science, LLC (TSI) today announced initiation of a …

  Distribution channels: Technology
• Published on September 4, 2018 - 15:31 GMT

  Sartorius Stedim Biotech and Repligen Corporation Partner to Introduce Next-Generation Perfusion-Enabled Bioreactors

  Development collaboration integrates Sartorius Stedim Biotech’s BIOSTAT® STR bioreactors and Repligen’s XCell™ ATF cell retention control technology Customers to benefit from simplified, scalable solutions for intensified cell culture Göttingen, Germany …

  Distribution channels: Technology
• Published on August 30, 2018 - 10:35 GMT

  SOTIO and PPF Complete Acquisition of Cytune Pharma

  Prague, Czech Republic, August 30, 2018 / B3C newswire / -- SOTIO, a biotechnology company owned by the PPF Group, announces today the completion of the acquisition of Cytune Pharma by PPF. SOTIO will continue to develop the lead program SO-C101 (RLI-15) …

  Distribution channels: Technology
• Published on August 29, 2018 - 10:26 GMT

  Orchard Therapeutics Expands Leadership Team with Appointments of Head of Corporate Communications and Head of Human Resources

  Boston, USA and London, UK, August 29, 2018 / B3C newswire / -- Orchard Therapeutics, a leading commercial-stage company dedicated to transforming the lives of patients with rare diseases through innovative gene therapies, today announced two additions to …

  Distribution channels: Technology